These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32105011

  • 1. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M, Karadağ ŞG, Ayaz NA.
    Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis.
    Tayfur AC, Topaloglu R, Gulhan B, Bilginer Y.
    Mod Rheumatol; 2015 Jul; 25(4):615-20. PubMed ID: 25800510
    [Abstract] [Full Text] [Related]

  • 4. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
    Shahani L.
    BMJ Case Rep; 2012 Aug 18; 2012():. PubMed ID: 22907859
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Juvenile dermatomyositis associated with autoantibodies to small ubiquitin-like modifier activating enzyme: a report of 4 cases from North India and a review of literature.
    Vignesh P, Barman P, Basu S, Mondal S, Ishran B, Kumrah R, Dod A, Garg R, Rawat A, Singh S.
    Immunol Res; 2023 Feb 18; 71(1):112-120. PubMed ID: 36278969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash.
    Huber AM, Kim S, Reed AM, Carrasco R, Feldman BM, Hong SD, Kahn P, Rahimi H, Robinson AB, Vehe RK, Weiss JE, Spencer C, Juvenile Dermatomyositis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol; 2017 Jan 18; 44(1):110-116. PubMed ID: 27803135
    [Abstract] [Full Text] [Related]

  • 11. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
    Cancarini P, Nozawa T, Whitney K, Bell-Peter A, Marcuz JA, Taddio A, Guo J, Dover S, Feldman BM.
    Semin Arthritis Rheum; 2022 Dec 18; 57():152104. PubMed ID: 36183479
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.
    Marco Puche A, Calvo Penades I, Lopez Montesinos B.
    Clin Exp Rheumatol; 2010 Dec 18; 28(1):135-40. PubMed ID: 20346254
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.
    Shiari R, Khalili M, Zeinali V, Shashaani N, Samami M, Moghaddamemami FH.
    Pediatr Rheumatol Online J; 2024 Jan 02; 22(1):2. PubMed ID: 38166943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.